AbbVie Inc. closed 5.34% below its 52-week high of $207.32, which the company reached on October 31st.
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
24/7 Wall St. on MSN4d
AbbVie Just Paid Investors: Here’s How Much They ReceivedAbbVie Inc. (NYSE: ABBV) is rewarding its shareholders once again with a quarterly dividend of $1.64, payable on Friday, Feb.
A total of 25 investors have a majority stake in the company with 46% ownership Using data from analyst forecasts alongside ...
GlobalData on MSN5d
AbbVie and Xilio to collaborate on antibody-based immunotherapiesAbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based ...
AbbVie Inc. offers a combination of rock-solid business mix, aggressive growth strategy, and shareholder-friendly capital allocation. The company holds strong positions in rapidly growing markets ...
AbbVie Inc. (NYSE:ABBV – Get Free Report) was the target of unusually large options trading activity on Monday. Stock ...
Feb. 13, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV ... 2025. Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback